These findings support the biological plausibility of a peripheral sensory contribution to GLP-1RA-associated changes in eating experience, but they do not establish that local taste-pathway modulation is sufficient to explain stable or consciously perceived alterations in flavour, food pleasure, or food-directed motivation in humans
It's important to emphasize that all GLP-1 medications have received approval from the Food and Drug Administration (FDA) for treating type 2 diabetes
We discuss mechanisms of action, safety and efficacy data, and the ongoing clinical trials that may shape the future of patient care
Ethics declarations Competing interests J.R., G.D., J.F., D.C.H
Roque believes a more science-informed culinary model is the future of menu development
Until those data arrive, claims about meaningful, reproducible benefits should be treated as hypotheses